Search

everythinglearnresearchcommunity

for

Search:↓

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

AR gene not major factor in female hair loss; different from male hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Finasteride works better for baldness in people with shorter gene repeats.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Acne is an important sign of androgen excess disorders in women.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The book explains how excess male hormones can affect various conditions like Polycystic Ovary Syndrome and Cushing's disease.

Finasteride may improve prostate cancer treatment outcomes.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.